Charlottes Web Holdings Inc (CWBHF)
0.1912
-0.01
(-4.65%)
USD |
OTCM |
Apr 26, 14:46
Charlottes Web Holdings Research and Development Expense (Quarterly)
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2020 | 1.984M |
| June 30, 2020 | 1.533M |
| March 31, 2020 | 0.766M |
| December 31, 2019 | 0.655M |
| September 30, 2019 | 0.255M |
| June 30, 2019 | 0.654M |
| March 31, 2019 | 0.191M |
| Date | Value |
|---|---|
| December 31, 2018 | 0.451M |
| September 30, 2018 | 0.132M |
| June 30, 2018 | 0.129M |
| March 31, 2018 | 0.126M |
| December 31, 2017 | 0.128M |
| September 30, 2017 | 0.157M |
| June 30, 2017 | 0.134M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.255M
Minimum
Sep 2019
1.984M
Maximum
Sep 2020
0.9745M
Average
0.7105M
Median
Research and Development Expense (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 0.004M |
| Palatin Technologies Inc | 5.554M |
| iBio Inc | 1.535M |
| Theriva Biologics Inc | 4.196M |
| Oragenics Inc | 11.04M |